This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
2/8/2024
At this time, I would like to welcome everyone to the Fibro Animal Health Corporation second quarter investor conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star then the number one on your telephone keypad. If you'd like to withdraw your question, press star one again. I would now like to turn the conference over to Dick Johnson, Chief Financial Officer. Please go ahead.
Thank you, Regina.
And welcome to the Fibro Animal Health Corporation earnings call for our fiscal second quarter ended December 31, 2023. As we said, my name is Dick Johnson. I'm the interim chief financial officer of Fibro Animal Health. I'm joined today by Jack Bentheim, Fibro's chairman, president, and chief executive officer. By Donnie Bentheim, director and executive vice president of corporate strategy. and also by Glenn David, the incoming Chief Financial Officer. Today, we'll cover financial performance for our second quarter and provide an update on our financial guidance for our fiscal year ending June 2024. At the conclusion of our remarks, we'll open the line for questions. I'd like to remind you that we're providing a simultaneous webcast of this call on our website, pahc.com. And also on that investor section of our website, you'll find copies of the earnings press release and second quarter form 10Q, as well as later today the transcript and slides that we're discussing on our call this morning. Turning to slide two, our remarks today will include our standard forward-looking statements and actual results could differ materially from those projections. For a list and description of certain factors that can cause results to differ, I refer you to the forward-looking statements section in our earnings press release. Our remarks include references to certain financial measures which were not prepared in accordance with generally accepted accounting principles or U.S. GAAP. I refer you to the non-GAAP financial information section in our earnings press release for a discussion of these measures. Reconciliations of these non-GAAP financial measures to the most directly comparable U.S. GAAP measures are included in the financial tables that accompany the earnings press release. We present our results on a GAAP basis and on an adjusted basis. Our adjusted results exclude acquisition-related items, unusual non-operational or non-recurring items, which would include things like stock-based compensation and in this most recent quarter, Brazil employment taxes item. Also, other income expenses separately reported in the P&L, including foreign currency losses, and also income taxes related to any of those pre-tax income adjustments, and any other unusual or non-recurring income tax items. So with that out of the way, let me introduce our Chairman, President, and Chief Executive Officer, Jack Bendheim, to share his opening remarks. Jack?
You're reading a preview of the PAHC Q2 2024 earnings call.
Free account.
